2004D-0188 - Draft Guidance for Industry on Premarketing Risk Assessment; Development and Use of Risk Minimization Action Plans; and Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment; Availability

  


  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3
  



  

  

  



  

  
Submitter : 
  

  
Mr. John Coster
  

  
Date & Time: 
  

  
07/28/2004 11:07:36
  



  

  
Organization : 
  

  
National Association of Chain Drug Stores
  



  

  
Category : 
  

  
Association
  



  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
Please find the attachment comments from the National Association of Chain Drug Stores.